The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Blood product inventory has been at historical lows during recent COVID-19 pandemic. This program will address how to handle inventory management in hospitals during shortages as well as engage hospital leaders and clinical stakeholders in management. Inventory management often falls to already overstretched blood bank staff, including the medical director. Our speakers will describe engaging key clinical stakeholders for patient blood management and also provide examples of transfusion triage teams with interdisciplinary members such as chief medical officer, clinical stakeholders (e.g. ICU attendings), and bioethics in addition to transfusion experts. Examples of algorithms for critical and severe shortages will also be shared.
All relevant financial relationships have been mitigated.
Learning Objectives:
List strategies to improve blood product utilization and patient blood management
Propose an interdisciplinary approach to inventory management during extreme blood shortages
Design and implement an algorithm to handle blood product shortages
Manage bleeding patient and triage blood supply during critical shortage
Speaker(s):
Kerry
O'Brien,
MD,
Beth Israel Deaconess Medical Center; Harvard Medical School
By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.